Development of an enhanced anti-pan-N-formylmethionine-specific antibody
BioTechniques · 2025
DOI: 10.1080/07366205.2025.2467583 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioTechniques, 2025. Verfasst von Dasom Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, Korea University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Antibodies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean government, Korea University.
Abstract (Originalsprache)
Both bacterial and eukaryotic ribosomes can initiate protein synthesis with formylmethionine (fMet), but detecting fMet-bearing peptides and fMet-bearing proteins has been challenging due to the lack of effective anti-pan-fMet antibodies. Previously, we developed a polyclonal anti-fMet antibody using a fMet-Gly-Ser-Gly-Cys pentapeptide that detects those fMet-bearing peptides and fMet-bearing proteins regardless of their sequence context. In this study, we significantly improved the antibody's specificity and affinity by using a mixture of fMet-Xaa-Cys tripeptides (Xaa, any of the 20 amino acids) as the immunogen. This newly optimized anti-fMet antibody is a powerful, cost-effective tool for detecting fMet-bearing proteins across species. Furthermore, this approach provides a foundation for developing anti-pan-specific antibodies targeting other N-terminal modifications through acylation, alkylation, oxidation, arginylation, etc. fMet-Gly-Ser-Gly-Cys (fMGSGC), fMet-dPEG4-Cys (fMdPEG4C), and fMet-Xaa-Cys (fMXC; Xaa, any of the 20 amino acids) were used as antigens to generate anti-pan-fMet-specific antibodies (anti-fMet antibodies). The quality of the raised antibodies was evaluated by immunoblotting using lysates from Escherichia coli (E. coli) DH5α cells and human kidney HK2 cells, as well as by enzyme-linked immunosorbent assay (ELISA) with purified fMet-bearing (fMet-) proteins, synthetic fMet-peptide, and their unformylated counterparts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences, Korea University, Seoul, Republic of Korea.
- Department of Physiology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
ORCID-Profile: Dasom Kim, Kyu-Sang Park, Cheol-Sang Hwang
Förderung
- Korean government
- Korea University
Zitieren
APA
Kim, D., Park, K. S., & Hwang, C. S. (2025). Development of an enhanced anti-pan-N-formylmethionine-specific antibody. BioTechniques. https://doi.org/10.1080/07366205.2025.2467583
Vancouver
Kim D, Park KS, Hwang CS. Development of an enhanced anti-pan-N-formylmethionine-specific antibody. BioTechniques. 2025. doi:10.1080/07366205.2025.2467583
BibTeX
@article{Kim2025,
author = {Kim, Dasom and Park, Kyu-Sang and Hwang, Cheol-Sang},
title = {Development of an enhanced anti-pan-N-formylmethionine-specific antibody},
journal = {BioTechniques},
year = {2025},
doi = {10.1080/07366205.2025.2467583}
}
EUVIMED